查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1307249

直接面對消費者的基因檢測市場：按類型、管道和功能分類 - 2023-2030 年全球預測

Direct-to-Consumer Genetic Testing Market by Type, Channel, Function - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球直接面對消費者的基因檢測市場預計將大幅成長，預計2023年將達到20.2322億美元，複合年成長率為17.19%，預計2030年將達到61.522億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球直接面對消費者的基因檢測市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 直接面對消費者的基因檢測的全球市場規模和預測是多少？

2.在預測期內，COVID-19 影響全球直接面對消費者的基因檢測市場的抑制要素和影響有哪些？

3. 在預測期內，全球直接面對消費者的基因檢測市場需要投資哪些產品/細分市場/應用/領域？

4、全球直接面對消費者的基因檢測市場有哪些競爭策略？

5. 全球直接面對消費者的基因檢測市場的技術趨勢和法律規範是什麼？

6. 全球直接面對消費者的基因檢測市場主要供應商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球直接面對消費者的基因檢測市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 希望更多地控制自己的醫療保健的消費者的範式轉變
      • 提高對基因組檢測和遺傳疾病風險的認知
      • 人口高齡化加劇和慢性病患病率上升
      • 對評估血統和祖先的好奇心增加
    • 抑制因素
      • 相關科學、技術和臨床問題
      • 第一修正案關於廣告中的誠實、忠於事實和真相的問題
    • 機會
      • 用於當前和未來基因診斷的下一代測序和生物晶片
      • 開發滿足客戶需求的線上應用程式
    • 任務
      • 解釋測試結果的複雜性
      • 醫生缺乏足夠的遺傳學知識
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化
    • 價格分析
      • 疾病風險與健康
      • 祖先或家譜
      • 親屬關係
      • 生活方式
    • 區域法規結構
    • 區域運輸 DNA 提取物的進出口狀況
    • DNA序列市場的基因組檢測預測

第6章 直接面對消費者的基因檢測市場：按類型

  • 線粒體DNA測試
  • 單核苷酸多態性檢測
  • Y染色體測試

第7章 直接面對消費者的基因檢測市場（按管道）

  • 離線
  • 線上的

第8章 直接面對消費者的基因檢測市場：按功能分類

  • 血統和種族
  • 癌症篩查
    • 遺傳性癌症
      • 血癌
      • 乳腺癌
      • 卵巢癌
    • 散發性癌症
  • 遺傳病攜帶者狀況
  • 新生兒篩檢
  • 特徵
  • 健康

第9章 美洲直接面對消費者的基因檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區直接面對消費者的基因檢測市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲直接面對消費者的基因檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-4312A385A4C4

The Global Direct-to-Consumer Genetic Testing Market is forecasted to grow significantly, with a projected USD 2,023.22 million in 2023 at a CAGR of 17.19% and expected to reach a staggering USD 6,152.20 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Direct-to-Consumer Genetic Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Direct-to-Consumer Genetic Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Mitochondrial DNA Testing, Single Nucleotide Polymorphism Testing, and Y Chromosome Testing. The Mitochondrial DNA Testing is projected to witness significant market share during forecast period.

Based on Channel, market is studied across Offline and Online. The Offline is projected to witness significant market share during forecast period.

Based on Function, market is studied across Ancestry & Ethnicity, Cancer Screening, Genetic Disease Carrier Status, New Baby Screening, Traits, and Wellness. The Cancer Screening is further studied across Hereditary Cancer and Sporadic Cancer. The Hereditary Cancer is further studied across Blood Cancer, Breast Cancer, and Ovarian Cancer. The New Baby Screening is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Direct-to-Consumer Genetic Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Direct-to-Consumer Genetic Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Direct-to-Consumer Genetic Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Direct-to-Consumer Genetic Testing Market?

4. What is the competitive strategic window for opportunities in the Global Direct-to-Consumer Genetic Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Direct-to-Consumer Genetic Testing Market?

6. What is the market share of the leading vendors in the Global Direct-to-Consumer Genetic Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Direct-to-Consumer Genetic Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Direct-to-Consumer Genetic Testing Market, by Type, 2022 vs 2030
  • 4.3. Direct-to-Consumer Genetic Testing Market, by Channel, 2022 vs 2030
  • 4.4. Direct-to-Consumer Genetic Testing Market, by Function, 2022 vs 2030
  • 4.5. Direct-to-Consumer Genetic Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Paradigm shift among consumers seeking greater control over their own healthcare
      • 5.1.1.2. Rising awareness about genome testing and risk of genetic diseases
      • 5.1.1.3. High aging population coupled with growing prevalence of chronic disorders
      • 5.1.1.4. Increased inquisitiveness about the assessment of lineage and ancestry
    • 5.1.2. Restraints
      • 5.1.2.1. Related scientific, technical, and clinical issues
      • 5.1.2.2. First amendment issues of honesty, fidelity to facts, and truth-in-advertising
    • 5.1.3. Opportunities
      • 5.1.3.1. Next-generation sequencing and bio-chip for present and future genetic diagnosis
      • 5.1.3.2. Development of online applications to serve customer needs
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity of test result interpretation
      • 5.1.4.2. Lack of adequate physician knowledge about genetics
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Pricing Analysis
      • 5.9.1.1. Disease Risk and Health
      • 5.9.1.2. Ancestry or Genealogy
      • 5.9.1.3. Kinship
      • 5.9.1.4. Lifestyle
    • 5.9.2. Regulatory Framework, By Geography
    • 5.9.3. State of Import & Export of DNA Extracts for Shipping, By Geography
    • 5.9.4. DNA Sequences Market Prospects for Genome Testing

6. Direct-to-Consumer Genetic Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Mitochondrial DNA Testing
  • 6.3. Single Nucleotide Polymorphism Testing
  • 6.4. Y Chromosome Testing

7. Direct-to-Consumer Genetic Testing Market, by Channel

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. Online

8. Direct-to-Consumer Genetic Testing Market, by Function

  • 8.1. Introduction
  • 8.2. Ancestry & Ethnicity
  • 8.3. Cancer Screening
    • 8.3.1. Hereditary Cancer
      • 8.3.1.1. Blood Cancer
      • 8.3.1.2. Breast Cancer
      • 8.3.1.3. Ovarian Cancer
    • 8.3.2. Sporadic Cancer
  • 8.4. Genetic Disease Carrier Status
  • 8.5. New Baby Screening
  • 8.6. Traits
  • 8.7. Wellness

9. Americas Direct-to-Consumer Genetic Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Direct-to-Consumer Genetic Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Direct-to-Consumer Genetic Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2022 VS 2030 (%)
  • FIGURE 6. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2022 VS 2030 (%)
  • FIGURE 7. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. DIRECT-TO-CONSUMER GENETIC TESTING MARKET DYNAMICS
  • FIGURE 9. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL DNA TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y CHROMOSOME TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 9. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 12. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY & ETHNICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 14. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 16. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SPORADIC CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GENETIC DISEASE CARRIER STATUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEW BABY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
  • TABLE 234. DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 235. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 236. DIRECT-TO-CONSUMER GENETIC TESTING MARKET LICENSE & PRICING